Proprietary AI analyst is now available

Rentokil Initial Valuation Multiples

Discover Rentokil Initial's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Aramark, Madison Air, Sodexo, Elis and more.

Rentokil Initial Overview

About Rentokil Initial

Rentokil Initial is the largest global provider of route-based pest control and commercial hygiene services, operating in 89 countries, with its largest operations in the United States following the acquisition of Terminix. The group also offers a range of specialist route-based services, including office and commercial space plant care, property care, and workwear rentals. The group serves a diverse client base of global food producers, hotel chains, industrial goods companies, restaurants, and individual residential customers.


Founded

2005

HQ

United Kingdom

Employees

65.6K

Financials (LTM)

Revenue: $7B
EBITDA: $2B

EV

$19B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Rentokil Initial Financials

Rentokil Initial reported last 12-month revenue of $7B and EBITDA of $2B.

In the same LTM period, Rentokil Initial generated $2B in EBITDA and $688M in net income.

Revenue (LTM)


Rentokil Initial P&L

In the most recent fiscal year, Rentokil Initial reported revenue of $7B and EBITDA of $1B.

Rentokil Initial is profitable as of last fiscal year, with gross margin of 83%, EBITDA margin of 22%, and net margin of 9%.

See analyst estimates for Rentokil Initial
LTMLast FY202320242025202620272028
Revenue$7B$7B$7B$7B$7B
Gross Profit-$6B$6B$6B$6B
Gross Margin-83%83%84%83%
EBITDA$2B$1B$1B$1B$1B
EBITDA Margin22%22%22%20%17%
EBIT Margin16%15%13%11%10%
Net Profit$688M$654M$485M$385M$470M
Net Margin10%9%7%6%7%
Net Debt-$3B---

Financial data powered by Morningstar, Inc.

Rentokil Initial Stock Performance

Rentokil Initial has current market cap of $15B, and enterprise value of $19B.

Market Cap Evolution


Rentokil Initial's stock price is $6.03.

Rentokil Initial share price decreased by 0.1% in the last 30 days, and increased by 28.3% in the last year.

Rentokil Initial has an EPS (earnings per share) of $0.26.

See more trading valuation data for Rentokil Initial
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$19B$15B-0.1%-0.1%-4.8%28.3%$0.26

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Rentokil Initial Valuation Multiples

Rentokil Initial trades at 2.7x EV/Revenue multiple, and 12.4x EV/EBITDA.

See NTM and 2027E valuation multiples for Rentokil Initial

EV / Revenue (LTM)


Rentokil Initial Financial Valuation Multiples

As of June 13, 2026, Rentokil Initial has market cap of $15B and EV of $19B.

Rentokil Initial has a P/E ratio of 22.1x.

LTMLast FY202320242025202620272028
EV/Revenue2.7x2.8x2.8x2.8x2.8x
EV/EBITDA12.4x12.7x12.9x13.7x15.8x
EV/EBIT17.0x17.8x20.8x25.0x28.9x
EV/Gross Profit-3.3x3.3x3.3x3.3x
P/E22.1x23.2x31.3x39.4x32.3x
EV/FCF29.6x27.0x28.4x32.7x27.0x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Rentokil Initial Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Rentokil Initial Margins & Growth Rates

Rentokil Initial grew revenue by 5% and EBITDA by 5% in the last fiscal year.

In the most recent fiscal year, Rentokil Initial reported gross margin of 83%, EBITDA margin of 22%, and net margin of 9%.

See estimated margins and future growth rates for Rentokil Initial

Rentokil Initial Margins

Last FY202420252026202720282029
Gross Margin83%84%83%86%
EBITDA Margin22%20%17%22%
EBIT Margin15%11%10%16%
Net Margin9%6%7%10%
FCF Margin10%9%10%9%

Rentokil Initial Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth5%(0%)1%5%
Gross Profit Growth9%0%0%9%
EBITDA Growth5%(6%)(13%)31%
EBIT Growth10%(17%)(13%)78%
Net Profit Growth12%(21%)22%55%
FCF Growth(5%)(13%)21%(5%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Rentokil Initial Operational KPIs

Rentokil Initial's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.

Rentokil Initial's Rule of 40 is 27% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Rentokil Initial's Rule of X is 34% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Rentokil Initial
LTMLast FY202320242025202620272028
Rule of 4026%27%---
Bessemer Rule of X34%34%---
Revenue per Employee-$0.1M---
Opex per Employee-$0.1M---
Opex to Revenue-74%70%73%74%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Rentokil Initial Competitors

Rentokil Initial competitors include Aramark, Madison Air, Sodexo, Elis, ISS World, Alliance Laundry Systems, UniFirst, Wuchan Zhongda Group Co and Brookfield Business Partners.

Most Rentokil Initial public comparables operate across Business Services and ClimateTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Aramark1.1x1.0x14.7x13.4x
Madison Air7.1x7.0x28.1x25.9x
Sodexo0.5x0.5x7.1x8.3x
Elis2.0x1.9x5.6x5.5x
ISS World0.6x0.6x9.4x9.1x
Alliance Laundry Systems4.0x3.9x15.7x15.2x
UniFirst1.9x1.9x14.0x14.6x

This data is available for Pro users. Sign up to see all Rentokil Initial competitors and their valuation data.

Start Free Trial

Rentokil Initial VC Funding History

Before going public, Rentokil Initial raised $39M in total equity funding, across 1 round.

Last private valuation of Rentokil Initial was $14B, after raising $39M in December 2024 from Trian Fund Management.


Rentokil Initial Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
Dec-24Undisclosed stageTrian Fund Management$39M$14BRentokil Initial plc is a global leader in pest control and hygiene & wellbeing services, operating in over 80 countries with approximately 68,500 employees. The company generates around 80% of its revenue from pest control, 16% from hygiene & wellbeing under the Initial brand, and the remainder from workwear, with North America accounting for the majority of revenue, particularly following the 2022 Terminix acquisition. In 2024, group revenue reached £5,436 million at actual exchange rates (AER), up 1.1% from £5,375 million in 2023, while adjusted operating profit was £834 million, down 7.0%. Trian Fund Management, led by activist investor Nelson Peltz, initiated its engagement with Rentokil Initial by disclosing a 2.26% stake in June 2024 and appointing Brian Baldwin to the board effective October 1, 2024. On December 11-13, 2024, Trian purchased an additional 7.5 million ordinary shares at 413.4 pence per share, valued at approximately £31 million, bringing its profile among the top ten shareholders. This purchase occurred amid Rentokil's market capitalization of around £10.44-10.5 billion ($13.3 billion), with shares down over a third in the prior 12 months due to US underperformance post-Terminix integration challenges. Financially, Rentokil reported group adjusted operating margin of 15.4% for 2024, with North America at 17.1%, adjusted PBT of £703 million, and net debt to EBITDA at 2.9x. Enterprise value stood at £13.3 billion, with 24% debt-funded. The company trades at about 27 times earnings, a discount to US peers like Ecolab (42x) and Rollins (53x). Trian has engaged management on strategies to enhance shareholder value, drawing parallels to its successful activism at Ferguson plc. Progress on Terminix integration included the first branch systems completion covering $373 million in revenues. Regional adjusted operating profit in non-North America areas rose 7.0% to £101 million, though margins dipped due to acquisitions like lower-margin DCUK. Cash flow conversion was 80.0%, with £172 million spent on acquisitions and total FY24 dividend of 9.09 pence per share.

Acquisitions by Rentokil Initial

Rentokil Initial has acquired 14 companies to date.

Last acquisition by Rentokil Initial was on December 14th 2021. Rentokil Initial acquired Terminix for $7B (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Rentokil Initial

Terminix
Vector Disease Control International
Samson HealthCare Services
Residex LLC
Description
Terminix is a Memphis-headquartered pest control company providing residential and commercial services across the United States. The firm deploys treatments against termites, mosquitoes, rodents, bed bugs, and ants through branches in all 50 states. Part of Rentokil Initial since 2022, Terminix employs Branch Associates trained by entomologists for customized protection plans including guarantees. The company maintains Nix Pest Guarantee for ongoing service.
Vector Disease Control International is a provider of mosquito surveillance and control services across the United States and Caribbean. Headquartered in Indianapolis, Indiana, it operates an in-house laboratory for species identification and arbovirus testing, deploys ground and aerial larviciding, and conducts weekly trapping at over 10,000 sites annually for public health agencies and resorts.
Samson HealthCare Services is a Sydney-based provider of commercial washroom hygiene solutions across New South Wales and the Australian Capital Territory. The company installs and maintains air fresheners, soap dispensers, toilet wipe stations, sanitary disposal bins, and sharps containers from depots in Wetherill Park and Newcastle. Servicing offices, hospitals, schools, and hospitality venues, it covers areas from Lithgow to the South Coast since establishing operations in the early 2000s.
Residex LLC is a distributor of pest control and turf management products in the eastern United States. From its North Carolina headquarters, it stocks termiticides, rodenticides, insecticides, fungicides, herbicides, and fertilizers. The inventory supports pest exterminators and landscapers with application equipment and safety gear.
HQ CountryUnited StatesUnited StatesAustraliaUnited States
HQ City
Memphis, TN
Little Rock, AR
Bradford
Detroit, MI
Deal Date14 Dec 202113 Nov 201730 Sep 20167 Jul 2016
Valuation$7Bundisclosedundisclosed$30M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Rentokil Initial acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Rentokil Initial

When was Rentokil Initial founded?Rentokil Initial was founded in 2005.
Where is Rentokil Initial headquartered?Rentokil Initial is headquartered in United Kingdom.
How many employees does Rentokil Initial have?As of today, Rentokil Initial has over 65K employees.
Is Rentokil Initial publicly listed?Yes, Rentokil Initial is a public company listed on London Stock Exchange.
What is the stock symbol of Rentokil Initial?Rentokil Initial trades under RTO ticker.
When did Rentokil Initial go public?Rentokil Initial went public in 1969.
Who are competitors of Rentokil Initial?Rentokil Initial main competitors include Aramark, Madison Air, Sodexo, Elis, ISS World, Alliance Laundry Systems, UniFirst, Wuchan Zhongda Group Co, Brookfield Business Partners.
What is the current market cap of Rentokil Initial?Rentokil Initial's current market cap is $15B.
What is the current revenue of Rentokil Initial?Rentokil Initial's last 12 months revenue is $7B.
What is the current revenue growth of Rentokil Initial?Rentokil Initial revenue growth (NTM/LTM) is 5%.
What is the current EV/Revenue multiple of Rentokil Initial?Current revenue multiple of Rentokil Initial is 2.7x.
What is the current EBITDA of Rentokil Initial?Rentokil Initial's last 12 months EBITDA is $2B.
What is Rentokil Initial's EBITDA margin?Rentokil Initial's last 12 months EBITDA margin is 22%.
What is the current EV/EBITDA multiple of Rentokil Initial?Current EBITDA multiple of Rentokil Initial is 12.4x.
What is the current FCF of Rentokil Initial?Rentokil Initial's last 12 months FCF is $643M.
What is Rentokil Initial's FCF margin?Rentokil Initial's last 12 months FCF margin is 9%.
What is the current EV/FCF multiple of Rentokil Initial?Current FCF multiple of Rentokil Initial is 29.6x.
How many companies Rentokil Initial has acquired to date?As of June 2026, Rentokil Initial has acquired 14 companies.
What was the largest acquisition by Rentokil Initial?$7B acquisition of Terminix on 14th December 2021 was the largest M&A Rentokil Initial has done to date.
What companies Rentokil Initial acquired?Rentokil Initial acquired Terminix, Residex LLC, Abadi Hygiene Services, Buffalo Exterminating, PestconePlus, Vector Disease Control International, Peter Cox Property Care, Sagrip, Grupo Bestway, Oliver Exterminating Co., and 4 other companies.
In how many companies Rentokil Initial has invested to date?Rentokil Initial hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Rentokil Initial

Lists including Rentokil Initial

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial